DFA
PJP icon

DHJJ Financial Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

DHJJ Financial Advisors’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.2K Buy
349
+2
+0.6% +$211 0.01% 453
2025
Q4 		$36.3K Hold
347
– – 0.01% 426
2025
Q3 		$32.1K Buy
347
+1
+0.3% +$88 0.01% 428
2025
Q2 		$27.6K Buy
+346
New +$27.6K 0.01% 433

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DHJJ Financial Advisors's PJP Position: Q1 2026 in Review

DHJJ Financial Advisors increased its Invesco Pharmaceuticals ETF (PJP) stake by 0.58% in Q1 2026, buying an estimated $211 and bringing the position to 349 shares worth $36.2K. The position accounts for 0.01% of the portfolio, ranked #453.

DHJJ Financial Advisors first reported a position in PJP in Q2 2025 and has held it in 4 quarters since. The position peaked at $36.3K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • DHJJ Financial Advisors held 349 shares of Invesco Pharmaceuticals ETF worth $36.2K as of Q1 2026.
  • DHJJ Financial Advisors bought 2 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $211.
  • Invesco Pharmaceuticals ETF made up 0.01% of DHJJ Financial Advisors's portfolio in Q1 2026, its #453 holding.
  • DHJJ Financial Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2025 and has held it in 4 quarters since.
  • DHJJ Financial Advisors's Invesco Pharmaceuticals ETF position peaked at $36.3K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on DHJJ Financial Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.